No abstract available
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
COVID-19 / diagnosis
-
COVID-19 / epidemiology*
-
COVID-19 / immunology
-
COVID-19 / therapy
-
Female
-
Germany / epidemiology
-
Humans
-
Immune Checkpoint Inhibitors / adverse effects
-
Immune Checkpoint Inhibitors / therapeutic use*
-
Male
-
Melanoma / drug therapy*
-
Melanoma / epidemiology
-
Melanoma / immunology
-
Middle Aged
-
Prognosis
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Registries
-
Risk Assessment
-
Risk Factors
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / epidemiology
-
Skin Neoplasms / immunology
Substances
-
Immune Checkpoint Inhibitors
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor